🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Prospective, open label single site study to demonstrate the safety and eff...
Status
Completed
Location
Centre hospitalier universitaire de Sherbrooke
Start Date
2014-09-01
Trial ID
NCT02307175
The purpose of the present study is to evaluate the ability of 99mTc-TM to ...
Status
Terminated
Location
Johns Hopkins Bayview Hospital
Start Date
2022-03-01
Trial ID
NCT05236387
Treatments Being Tested
The purpose of the study is to examine the rate of absorption of subcutaneo...
Status
Completed
Location
Aalborg University Hospital
Start Date
2020-09-01
Trial ID
NCT04536324
Treatments Being Tested
This is a multiple-center Phase 2 study designed to expand the patient safe...
Status
Completed
Location
Baptist Health South Florida
Start Date
2009-06
Trial ID
NCT00865319
Treatments Being Tested
This was a multicenter, multi-reader, open-label, Phase 2 study assessing t...
Status
Completed
Location
City of Hope National Cancer Center
Start Date
2012-08
Trial ID
NCT01667536
Treatments Being Tested
To estimate the prevalence of transthyretin cardiac amyloidosis (TTR-CA) am...
Status
Completed
Location
Mayo Clinic in Rochester
Start Date
2017-12-01
Trial ID
NCT03414632
Treatments Being Tested
Recently the investigators have shown that the SN procedure performed throu...
Status
Terminated
Location
Maastricht UMC, Dept. Obst&Gyn
Start Date
2016-01-01
Trial ID
NCT02540551
Treatments Being Tested
This study is recruiting patients already scheduled for a single photon emi...
Status
Terminated
Location
Northwestern University
Start Date
2011-10
Trial ID
NCT01499654
Treatments Being Tested
Title ThoHSpEkt Study Design Pilot Study concerning the technical operativ...
Status
Terminated
Location
Cantonal Hospital St.Gallen
Start Date
2013-11
Trial ID
NCT02050724
This phase 2 trial studies how well panitumumab-IRDye800 works in identifyi...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2019-08-01
Trial ID
NCT03405142
Treatments Being Tested